A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer

PURPOSE/OBJECTIVE(S): To report results from our phase II study of stereotactic body radiotherapy (SBRT) delivering 36 Gy in 4 fractions for patients with localized prostate cancer. MATERIALS/METHODS: We enrolled 55 patients treated with SBRT delivering 36 Gy in 4 fractions between 2015 to 2018. All...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawakami, S., Tsumura, H., Satoh, T., Tabata, K., Sekiguchi, A., Kainuma, T., Nakano, M., Iwamura, M., Ishiyama, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978412/
https://www.ncbi.nlm.nih.gov/pubmed/35379264
http://dx.doi.org/10.1186/s13014-022-02037-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978412/
https://www.ncbi.nlm.nih.gov/pubmed/35379264
http://dx.doi.org/10.1186/s13014-022-02037-y

Ejemplares similares